A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants
NCT04555733 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2021-07-19
Summary
The primary objective of this study is to assess the pharmacokinetics (PK) of lemborexant and metabolites (M4, M9, and M10) in plasma in healthy Chinese participants following single and multiple oral doses of lemborexant.
Conditions
- Healthy Volunteer
Interventions
- DRUG
-
Lemborexant
Lemborexant oral tablets.
Sponsors & Collaborators
-
Eisai Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-26
- Primary Completion
- 2021-01-13
- Completion
- 2021-01-13
Countries
- China
Study Locations
More Related Trials
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAB5553A in Healthy Volunteers
NCT02528903 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject
NCT06389942 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Dose Asian Bridging Study
NCT01251731 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of IBI353 (Orismilast) in Chinese Healthy Adults
NCT05490316 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
NCT07058779 ·Status: RECRUITING ·Phase: PHASE1
-
An Open-label, Single Dose, Parallel Design, Phase 1 Clinical Study of LCB01-0371
NCT02529241 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Examine the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of TMC435 in Healthy Chinese Participants
NCT02071355 ·Status: COMPLETED ·Phase: PHASE1
-
A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers
NCT05397041 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of [14C]IBI351 in Healthy Subjects
NCT05626179 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants
NCT05070312 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers
NCT05663593 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants
NCT06502379 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects
NCT05045781 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated
NCT03206632 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of IBI355 in Healthy Volunteers
NCT06416787 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects
NCT00414778 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers
NCT02746302 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects
NCT05907382 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.
NCT04958291 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
NCT07057726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults
NCT07235137 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants
NCT07281703 ·Status: RECRUITING ·Phase: PHASE1
-
Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
NCT01638598 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
NCT03641573 ·Status: COMPLETED ·Phase: PHASE1